1Eble JN SG, Epstein JI, Sesterhenn IA. World Health Organisation classification of tumors, pathology and genetics of tumors of the genitourinary system and male genital organs [ M ]. IARC Press, Ly- on, 2004.
3Amato R J, Ro JY, Ayala AG, et al. Risk-adapted treatment for patients with clinical stage I nonseminomatous germ cell tumor of the testis. Urology, 2004, 63 (1) : 144-148, 148-149.
4Fossa SD, Cvancarova M, Chen L, et al. Adverse prognostic fac- tors for testicular cancer-specific survival: A population-based study of 27, 948 patients. J Clin Oncol, 2011, 29(8): 963- 970.
5Richie JP, Syeele GS. Neoplasms of the testis. Campbell~ Urolo- gy, 8th. ed; AI. W P E, Phiadelphia: WB Saunders, 2002, 2876-2919.
6Keskin S, Ekenel M, Basaran M, et al. Surveillance results of pa- tients with stage I nonseminomatous germ cell testicular cancer. Onkologie, 2011, 34(4) : 173-176.
7Ondrus D, Goncalves F, Kausitz J, et al. The value of prognostic factors in the management of stage I nonseminomatous germ cell testicular tumors (NSGCTT). Neoplasma, 1996, 43 (3) : 195- 197.
8Pont J, Albrecht W, Postner G, et al. Adjuvant chemotherapy for high-risk clinical stage I nonseminomatous testicular germ cell cancer: Long-term results of a prospective trial. J Clin Oncol,1996, 14(2) : 441-448.
9Cullen MH, Stenning SP, Parkinson MC, et al. Short-course ad- juvant chemotherapy in high-risk stage I cell tumors of the testis: A Medical Research Council report. J Clin Oncol, 1996, 14(4): 1106-1113.
10Simmonds PD, Lee AH, Theaker JM, et al. Primary pure terato- ma of the testis. J Urol, 1996, 155(3) : 939-942.
